{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:47:16Z","timestamp":1785869236658,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.clim.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T02:46:25Z","timestamp":1484361985000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Hypoxia-inducible factor-1\u03b1 inhibition modulates airway hyperresponsiveness and nitric oxide levels in a BALB\/c mouse model of asthma"],"prefix":"10.1016","volume":"176","author":[{"given":"Carola","family":"Dewitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"McEachern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Akong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale G.","family":"Nagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Broide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5091-2660","authenticated-orcid":false,"given":"Laura E.","family":"Crotty Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.01.002_bb0005","series-title":"Summary Health Statistics for U.S. Adults: National Health Interview Survey","author":"NIAID","year":"2008"},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1526-0542(02)00308-1","article-title":"The role of allergy in the development of airway inflammation in children","volume":"4","author":"Babu","year":"2003","journal-title":"Paediatr. Respir. Rev."},{"issue":"7","key":"10.1016\/j.clim.2017.01.002_bb0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ni.1892","article-title":"The many paths to asthma: phenotype shaped by innate and adaptive immunity","volume":"11","author":"Kim","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-065X.2011.01032.x","article-title":"Human asthma phenotypes: from the clinic, to cytokines, and back again","volume":"242","author":"Bhakta","year":"2011","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaci.2006.10.035","article-title":"The predicting response to inhaled corticosteroid efficacy (PRICE) trial","volume":"119","author":"Martin","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2017.01.002_bb0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2017.01.002_bb0035","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1398-9995.2011.02594.x","article-title":"Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis","volume":"66","author":"Huerta-Yepez","year":"2011","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clim.2008.07.023","article-title":"2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model","volume":"129","author":"Huerta-Yepez","year":"2008","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.clim.2017.01.002_bb0045","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/eji.200939948","article-title":"HIF-1alpha inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium","volume":"40","author":"Kim","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.clim.2017.01.002_bb0050","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1081-1206(10)60971-4","article-title":"Expression of vascular endothelial growth factor and hypoxia-inducible factor in the airway of asthmatic patients","volume":"97","author":"Lee","year":"2006","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000189191","article-title":"Enhanced interferon-gamma gene expression in T cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient mice","volume":"149","author":"Guo","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0060","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0065","doi-asserted-by":"crossref","first-page":"L360","DOI":"10.1152\/ajplung.00158.2002","article-title":"Decreased alveolar oxygen induces lung inflammation","volume":"284","author":"Madjdpour","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"7","key":"10.1016\/j.clim.2017.01.002_bb0070","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1172\/JCI23865","article-title":"HIF-1alpha expression regulates the bactericidal capacity of phagocytes","volume":"115","author":"Peyssonnaux","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-012-0986-9","article-title":"Myeloid cell HIF-1alpha regulates asthma airway resistance and eosinophil function","volume":"91","author":"Crotty Alexander","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bjc.6604939","article-title":"Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy","volume":"100","author":"Harada","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.clim.2017.01.002_bb0085","doi-asserted-by":"crossref","first-page":"F1023","DOI":"10.1152\/ajprenal.90209.2008","article-title":"Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis","volume":"295","author":"Kimura","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2007.03.026","article-title":"Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading","volume":"255","author":"Shin","year":"2007","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.clim.2017.01.002_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"27","key":"10.1016\/j.clim.2017.01.002_bb0100","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/sj.onc.1210169","article-title":"YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt\/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia","volume":"26","author":"Sun","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.clim.2017.01.002_bb0105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.bbrc.2006.08.015","article-title":"Suppression of hypoxia inducible factor-1alpha (HIF-1alpha) by YC-1 is dependent on murine double minute 2 (Mdm2)","volume":"348","author":"Lau","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0110","first-page":"255","article-title":"A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent","volume":"29","author":"Kim","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.clim.2017.01.002_bb0115","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1158\/1535-7163.MCT-08-0074","article-title":"A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}","volume":"7","author":"Li","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1021\/np100228d","article-title":"The alternative medicine pawpaw and its acetogenin constituents suppress tumor angiogenesis via the HIF-1\/VEGF pathway","volume":"73","author":"Coothankandaswamy","year":"2010","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0130","doi-asserted-by":"crossref","first-page":"L29","DOI":"10.1152\/ajplung.00085.2003","article-title":"Allergic asthma in mice: what determines the phenotype?","volume":"285","author":"Kannan","year":"2003","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"12","key":"10.1016\/j.clim.2017.01.002_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00011-009-0054-2","article-title":"Mouse models of asthma: a comparison between C57BL\/6 and BALB\/c strains regarding bronchial responsiveness, inflammation, and cytokine production","volume":"58","author":"Gueders","year":"2009","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.clim.2017.01.002_bb0140","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000199715","article-title":"Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL\/6 and BALB\/c mice","volume":"149","author":"Van Hove","year":"2009","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2017.01.002_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000312128","article-title":"Strain-specific phenotypes of airway inflammation and bronchial hyperresponsiveness induced by epicutaneous allergen sensitization in BALB\/c and C57BL\/6 mice","volume":"152","author":"Kodama","year":"2010","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.clim.2017.01.002_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/01902140903360353","article-title":"Analysis of pulmonary allergic vasculitis with eosinophil infiltration in asthma model of mice","volume":"36","author":"Yamauchi","year":"2010","journal-title":"Exp. Lung Res."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000076131","article-title":"Do mouse models of allergic asthma mimic clinical disease?","volume":"133","author":"Epstein","year":"2004","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1081-1206(10)62201-6","article-title":"Understanding the pathogenesis of allergic asthma using mouse models","volume":"87","author":"Leong","year":"2001","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/ers.12.1","article-title":"Update on exhaled nitric oxide in pulmonary disease","volume":"6","author":"Spitale","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"issue":"9","key":"10.1016\/j.clim.2017.01.002_bb0170","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1074\/jbc.272.9.5375","article-title":"Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia","volume":"272","author":"Lee","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2013.02.004","article-title":"Hypoxia potentiates allergen induction of HIF-1alpha, chemokines, airway inflammation, TGF-beta1, and airway remodeling in a mouse model","volume":"147","author":"Baek","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2017.01.002_bb0180","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/sj.onc.1210169","article-title":"YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt\/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia","volume":"26","author":"Sun","year":"2007","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2007.04.026","article-title":"Methods to detect nitric oxide and its metabolites in biological samples","volume":"43","author":"Bryan","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.clim.2017.01.002_bb0190","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","article-title":"Transcriptional regulation of the vascular endothelial growth factor gene\u2013a concert of activating factors","volume":"65","author":"Pages","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.clim.2017.01.002_bb0195","first-page":"281","article-title":"Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium\/choroid organ cultures: p38, nuclear factor kappaB, and the vascular endothelial growth factor receptor-2\/phosphatidylinositol 3 kinase pathway","volume":"19","author":"Klettner","year":"2013","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.clim.2017.01.002_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/mi.2012.74","article-title":"The alveolar macrophages in asthma: a double-edged sword","volume":"5","author":"Balhara","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/imm.12071","article-title":"Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice","volume":"139","author":"Mizutani","year":"2013","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.clim.2017.01.002_bb0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3858\/emm.2011.43.5.028","article-title":"Alveolar macrophages modulate allergic inflammation in a murine model of asthma","volume":"43","author":"Bang","year":"2011","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.clim.2017.01.002_bb0215","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3892\/mmr.2016.5485","article-title":"Investigation of the antiasthmatic activity of Oridonin on a mouse model of asthma","volume":"14","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.clim.2017.01.002_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fimmu.2016.00237","article-title":"Aerobic exercise reduces asthma phenotype by modulation of the leukotriene pathway","volume":"7","author":"Alberca-Custodio","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.clim.2017.01.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.38","article-title":"The role of autophagy in allergic inflammation: a new target for severe asthma","volume":"48","author":"Liu","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.clim.2017.01.002_bb0230","first-page":"1732","article-title":"High mobility group box 1: a novel mediator of Th2-type response-induced airway inflammation of acute allergic asthma","volume":"7","author":"Ma","year":"2015","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.clim.2017.01.002_bb0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.183.1.109","article-title":"Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity","volume":"183","author":"Corry","year":"1996","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.clim.2017.01.002_bb0240","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.2500\/ajra.2014.28.4025","article-title":"The role of hypoxia-inducible factor 1alpha in allergic rhinitis","volume":"28","author":"Mo","year":"2014","journal-title":"Am. J. Rhinol. Allergy"},{"issue":"11","key":"10.1016\/j.clim.2017.01.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048618","article-title":"HIF-1alpha inhibition reduces nasal inflammation in a murine allergic rhinitis model","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161630537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161630537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:16:22Z","timestamp":1568718982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161630537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":48,"alternative-id":["S152166161630537X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.01.002","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia-inducible factor-1\u03b1 inhibition modulates airway hyperresponsiveness and nitric oxide levels in a BALB\/c mouse model of asthma","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}